but the 2023 American College of Cardiology/American Heart Association/American College of Clinical Pharmacy/Heart Rhythm Society Guideline for the Management and Diagnosis of Atrial Fibrillation ...

Dr. Ratika Parkash, MD, FRCPC, Cardiologist, discusses how stroke prevention with anticoagulant treatment is important in ...

There is an apparent underuse of warfarin in elderly patients with AF, as there is inconsistency in opinion among clinicians about who should receive anticoagulation. The risks of warfarin are ...

A study led by researchers at the Duke Clinical Research Institute found that just 46 of atrial fibrillation inpatients received a blood thinner at discharge. Disclaimer: AAAS and EurekAlert!

Nonetheless, among patients with ESKD and atrial fibrillation, anticoagulation may confer a survival benefit even when bleeding occurs, potentially due to the availability of anticoagulant ...

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence increases with age. Current data suggest that anticoagulation with warfarin or dabigatran is far superior to ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

Background: Atrial fibrillation (AF) is the most common arrhythmia and is associated with morbidity from ischemic stroke. Oral anticoagulant (OAC) therapy reduces stroke risk. Prior work has shown ...

Multidisciplinary coordination across prescribing teams, nursing, laboratory medicine, finance, and infusion centers is ...

Atrial fibrillation (A-fib) results from erratic signals in the upper chambers of the heart, causing an irregular heartbeat. It is a common arrhythmia and can cause a slow, normal, or fast heart rate.